ITEK, Inc.

As of March 31, 2026, ITEK, Inc. carries a market capitalization of 151.99B, placing it among publicly traded companies globally. Its enterprise value stands at 6.66B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, ITEK, Inc. has 26.21M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 2.95, and the price-to-book ratio stands at 0.80.

As of March 31, 2026, ITEK, Inc. trades at an EV/EBITDA multiple of 0.58 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.14 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 6.39 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 6.66B versus a market cap of 151.99B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, ITEK, Inc. maintains a current ratio of 3.04, meaning it holds 3.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 18.47, indicating elevated leverage, while an interest coverage ratio of 3.09 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended March 31, 2026, ITEK, Inc. posted a negative return on equity (ROE) of -6.62, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -4.87, reflecting losses generated across the asset base. The company generates approximately 177.78M in revenue per employee across its workforce of 263.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 30.86 indicates how many times ITEK, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, ITEK, Inc. recorded 1.06B in income tax expense. The company reported a pretax loss of -6.64B and -11.76B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, ITEK, Inc.'s stock has declined approximately 1.21% over the past 52 weeks. The 50-day moving average sits at 6,405.40, while the 200-day moving average is 6,703.58.

Over the twelve months ended March 31, 2026, ITEK, Inc. generated 46.76B in revenue and converted that into -11.76B in net income, yielding earnings per share of -324.17. EBITDA reached 11.46B, while operating income came in at 1.04B.

As of March 31, 2026, ITEK, Inc. holds 179.24B in cash and equivalents against 34.85B in total debt, resulting in a net debt position of -90.76B. Total book value stands at 189.58B, with working capital of 134.40B providing operational flexibility.

ITEK, Inc. produced 24.19B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -15.25B in capital expenditures, free cash flow totaled 8.94B - equivalent to 376.25 per share.

Over the twelve months ended March 31, 2026, ITEK, Inc. posted a gross margin of 17.19, reflecting its pricing power and cost economics. The operating margin of 2.23 and net profit margin of -25.16 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield stands at 6.49, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -34.79, meaning ITEK, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of March 31, 2026, ITEK, Inc. has an Altman Z-Score of 2.17, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.